THE NEXT GENERATION OF THERAPEUTIC PROTEINS Trademark Information

Trademark by GlycoFi, Inc.

Custom manufacture of protein, glycoprotein, antibodies through glycosylation, protein glycosylation, genetic engineering, protein production, glycosylation engineering and fermentation to the order and/or specification of others in the field of biotechnology

Research, development and consultation services in the field of biotechnology, namely, protein production, glycoprotein production, antibody production, protein glycosylation, genetic engineering, glycosylation engineering and fermentation

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (040)
Treatment of materials.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: THE NEXT GENERATION OF THERAPEUTIC PROTEINS
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
8/22/2007
Serial Number: 78421580
Filing Date: 5/19/2004
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Custom manufacture of protein, glycoprotein, antibodies through glycosylation, protein glycosylation, genetic engineering, protein production, glycosylation engineering and fermentation to the order and/or specification of others in the field of biotechnology
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 11/29/2005
Last Applicant/Owner:
GlycoFi, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("THERAPEUTIC PROTEINS")
Correspondent:
********
********
***** ****
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
8/22/2007
Correspondent Search:
SUSAN C. MATTSON is a correspondent of THE NEXT GENERATION OF THERAPEUTIC PROTEINS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on